Orthopedics · Medical Literature
Ultrasound- Versus Landmark-Guided Corticosteroid Injections for Shoulder Pain: Evaluating the Overlapping Meta-Analyses of Randomized Controlled Trials.
Abstract
Shoulder pain is frequently treated with corticosteroid injections administered via ultrasound-guided (USG) or landmark-guided (LMG) approaches. Despite the widespread use of these injections, consensus on their comparative efficacy is lacking due to conflicting results reported in prior meta-analyses. To compare overlapping meta-analyses of USG to those of LMG injections in order to resolve current discrepancies, determine the highest-quality evidence, and offer clear recommendations for clinical practice. A cross-sectional analysis. English-language systematic reviews and meta-analyses searched in PubMed, Embase, and Cochrane Library up to February 12, 2025, regarding USG management of shoulder pain. A comprehensive literature search was conducted to identify meta-analyses of randomized controlled trials (RCTs) that assessed USG and LMG corticosteroid injections in the treatment of shoulder pain. Methodological quality of the included meta-analyses was assessed, and the Assessment of Multiple Systematic Reviews (AMSTAR) scores were calculated. The Jadad decision algorithm was applied to determine the highest-quality evidence. The analysis encompassed 9 meta-analyses, the AMSTAR ratings of which ranged between 5 and 9. Through the Jadad algorithm, one high-quality study was identified. Its findings indicated that USG injections did not significantly outperform LMG injections in terms of pain relief or functional outcomes for subacromial bursa and glenohumeral joint targets. However, for injections involving the brachial bicipital groove, the USG approach demonstrated greater efficacy in alleviating pain. First, the restriction to English-language literature might have introduced language bias by excluding relevant non-Anglophone studies. Second, the included studies provided only Level II evidence, so this analysis could not establish clinical recommendations grounded in the highest tier (Level I) of empirical support. USG corticosteroid injections are recommended for targeting the brachial bicipital groove due to their superior efficacy in pain reduction, while LMG injections remain appropriate for the subacromial bursa or glenohumeral joint.
Clinical relevance
Among patients with shoulder pain treated with corticosteroid injections, does ultrasound-guided (USG) injection produce superior clinical outcomes compared to landmark-guided (LMG) injection, and which existing meta-analysis provides the highest-quality evidence to resolve discrepancies across the published literature? __SNAPSHOT__ {"studyDesign":"Cross-sectional analysis of overlapping meta-analyses of randomized controlled trials (overview of reviews / umbrella methodology)","setting":"Bibliographic databases (PubMed, Embase, Cochrane Library); search conducted through February 12, 2025; no single clinical institution","sampleSize":"9 meta-analyses included; aggregate patient-level n across constituent RCTs not reported in available abstract","population":"Adults with shoulder pain (encompassing diagnoses such as subacromial impingement syndrome, rotator cuff pathology, and related conditions) treated with corticosteroid injections in the included RCTs","intervention":"Ultrasound-guided (USG) corticosteroid injection into the shoulder","comparator":"Landmark-guided (LMG) corticosteroid injection into the shoulder","primaryOutcome":"Identification of the highest-quality meta-analytic evidence via AMSTAR scoring and application of the Jadad decision algorithm; clinical outcomes (pain relief, function, range of motion) as reported across the 9 included meta-analyses","followUp":"Variable across the included meta-analyses; overall follow-up duration not reported in the available abstract","fundingSource":"Not reported"}
Key findings
The analysis encompassed 9 meta-analyses assessing USG versus LMG corticosteroid injections for shoulder pain. Specific AMSTAR scores for individual meta-analyses, the identity of the highest-quality meta-analysis selected by the Jadad algorithm, pooled effect sizes, confidence intervals, and p-values for primary clinical outcomes (pain, function, range of motion) were not reported in the available abstract. Prior overlapping meta-analyses in this clinical space have yielded conflicting conclusions: some report statistically significant benefits of USG over LMG for early pain relief and mid-to-long-term abduction, while others find no significant difference in pain or functional outcomes at various time points. The Jadad decision algorithm was applied to select the 'best evidence' review from among the 9 discordant meta-analyses; the specific meta-analysis selected and its resultant clinical recommendation are not available from the truncated abstract. No adverse event data were reported in the available abstract.
Practice implications
NOTE: Only the abstract (truncated) was available for this summary; the full results, Jadad-selected meta-analysis, and clinical recommendations cannot be independently verified. This cross-sectional analysis of overlapping meta-analyses represents a methodologically appropriate approach to resolving discordance in the literature, using validated tools (AMSTAR for quality grading, Jadad algorithm for evidence selection). The study explicitly acknowledges that prior meta-analyses yield conflicting conclusions about the comparative superiority of USG over LMG shoulder injections. The Jadad algorithm has known reproducibility limitations — independent replication studies have shown it fails to select the same review in approximately 62% of cases — which must temper confidence in the algorithm-selected 'best evidence.' The findings nominally apply to adults with shoulder pain (predominantly subacromial impingement/rotator cuff pathology) receiving corticosteroid injections; patients with other shoulder pathologies (e.g., adhesive capsulitis, glenohumeral osteoarthritis) may have been underrepresented depending on constituent RCT inclusion criteria. Whether USG guidance confers a clinically important benefit — as opposed to a statistically significant one — over LMG technique in routine practice remains uncertain from the available abstract. Practice should not change based on the abstract alone; the full publication is required. __LIMITATIONS__ Only the truncated abstract was available; key results, AMSTAR scores, Jadad-selected review, and clinical conclusions cannot be assessed.,Cross-sectional analysis of overlapping meta-analyses is inherently limited by the quality and heterogeneity of the constituent RCTs within each included meta-analysis.,The Jadad decision algorithm has documented reproducibility concerns — independent replication fails to select the same review in ~62% of cases — limiting confidence in the 'best evidence' designation.,Heterogeneity in shoulder diagnoses, injection sites (subacromial bursa vs. glenohumeral joint vs. bicipital groove), corticosteroid agents and doses, and outcome measurement instruments across constituent RCTs is an expected but unquantifiable source of confounding.,Restriction to English-language publications introduces language bias.,Literature search was cut off February 2025; subsequently published RCTs are excluded.,Aggregate patient-level sample size across included RCTs was not reported in the available abstract, precluding assessment of power.,Funding source and potential conflicts of interest were not reported in the abstract, limiting bias assessment.,Surrogate outcomes (accuracy of injection) versus patient-centered outcomes (pain, function, quality of life) may not have been adequately distinguished across included meta-analyses.,Long-term follow-up data (beyond 6 months) may be sparse in the underlying RCT literature, limiting conclusions about durability of effect. __BOTTOM_LINE_CATEGORY__ low_certainty __BOTTOM_LINE__ This cross-sectional analysis of 9 overlapping meta-analyses applied AMSTAR quality assessment and the Jadad decision algorithm to identify the highest-quality evidence on USG versus LMG corticosteroid injections for shoulder pain — a clinically important question given persistent discordance in the literature. The specific findings, recommended practice guidance, and Jadad-selected 'best evidence' meta-analysis could not be extracted from the truncated abstract; clinicians should access the full publication before modifying injection practice. Until the complete results are reviewed, the existing balance of evidence suggests USG may offer modest advantages in injection accuracy and select early outcomes, but whether this translates to a clinically meaningful and durable benefit over competently performed LMG injection in routine practice remains unresolved.